Search

everythinglearnresearchcommunity

for

Search:↓

Primary healthcare clinics are key in managing chemotherapy side effects using various medications and treatments.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Vitamin D is made by the skin, helps control various body functions, and affects skin health and immunity.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

SLVs help maintain muscle stretch sensitivity and could aid in treating hypertension and muscle spasticity.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

The review provided information on various treatments to stop hair thinning and increase hair density in people with common genetic hair loss.

Targeting CXXC5 and GSK-3β may help treat male pattern baldness.

Hair growth phase and certain genes can speed up wound healing, while an inflammatory mediator can slow down new hair growth after a wound. Understanding these factors can improve tissue regeneration during wound healing.

Vitamin D is important for bones, hair, blood pressure, and breast development.

Two sisters with rickets and hair loss had a genetic issue with vitamin D processing, and only improved when given phosphorus supplements.

Hair can regrow in large wounds through a process similar to how hair forms in embryos, and understanding this could lead to new treatments for hair loss or scarring.

VDR regulation varies by tissue and is crucial for its biological functions.

A protein called HMGB1 helps hair grow by affecting prostaglandin metabolism.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Vitamin D is crucial for bone health and preventing serious diseases.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Using lidocaine before keloid injections makes the treatment more comfortable for patients.

Gypenosides from Gynostemma pentaphyllum were found to have anti-aging effects, increasing skin collagen and reducing wrinkles.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Cosmetic foam product reduces hair loss and increases hair density in men.